Adjuvant
US8883170B2 · kind B2 · utility
0Cited by
2References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 3, 2008 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Aug 10, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and immunogenic compositions for generating an immune response against Marburg virus are provided. The immunogenic composition includes antigens obtained from a Marburg viral strain in combination with an oleanolic acid triterpene adjuvant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.